<DOC>
	<DOC>NCT00190749</DOC>
	<brief_summary>This study will assess whether olanzapine and/or risperidone affect the way the human body uses sugar in the blood.</brief_summary>
	<brief_title>Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>1865 years old Diagnosed with Schizophrenia or Schizoaffective disorder Ability to visit the doctor's office for scheduled visits Women who are pregnant or breastfeeding Have a body mass index (BMI) greater than 40 Have diabetes, heart disease or any other unstable illness Have known positive human immunodeficiency virus (HIV) Are currently taking olanzapine, risperidone, clozapine, glucocorticoids, injectable antipsychotics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2010</verification_date>
</DOC>